Compare Sinergi Inti Plastindo Tbk. (ESIP) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinergi Inti Plastindo Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Sinergi Inti Plastindo Tbk. trades at Rp123 (market cap 135.41B, 9.53M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp312 (market cap 821.5B, 25.59M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 6.1× Sinergi Inti Plastindo Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.59M versus 9.53M). Which is the better fit depends on your goals.
| ESIP | RSCH | |
|---|---|---|
Market Cap | 135.41B | 821.5B |
Volume | 9.53M | 25.59M |
Lot | 95.29K | 255.95K |
Turnover | 1.16B | 7.95B |
Average Price | 121.44 | 310.77 |
Value | 1.16B | 7.95B |
Indicative Equilibrium Price | 123 | 312 |
Indicative Equilibrium Volume | 1.58K | 10 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinergi Inti Plastindo Tbk.
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
